CVS Health Corp. is sticking with its profit guidance for 2022, according to a regulatory filing published Thursday. The drug store chain said senior management would be meeting with investors during the rest of June and will reaffirm the guidance offered on May 4. The company is expecting per-share earnings to range from $6.93 to $7.13. It expects adjusted EPS to range from $8.20 to $8.40, compared with a FactSet consensus of $8.35. Shares were slightly higher premarket but are down 9% in the year to date, while the S&P 500 has fallen 13.7%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.